Society for Endocrinology - a world-leading authority on hormones

UPDATE 1-Ipsen keeps 2009, 2012 goals, to triple trials (Reuters, 8 January 2008)

12 Jan 2009


French drugmaker Ipsen claims it can still reach its 2009 and 2012 targets, which include reaching a 10% share of the US market for its endocrinology drug Somatuline.

Full article